Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2018 1
2019 1
2022 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Sustained drug-free remission in giant cell arteritis.
Narváez J, Domínguez M, Galíndez E, Mendizábal J, Abasolo L, Lluch J, Loricera J, Garrido N, Castañeda S, Moya P, Larena C, Estrada P, Galisteo C, Riveros Frutos A, Ortiz Sanjuán F, Salman T, Vasques Rocha M, Iñiguez CL, García González M, Blanco R; ARTESER Project Collaborative Group. Narváez J, et al. Rheumatology (Oxford). 2025 May 1;64(5):2919-2927. doi: 10.1093/rheumatology/keae644. Rheumatology (Oxford). 2025. PMID: 39589919
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry.
Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Sánchez Martín J, Narváez J, Calvo I, Mendizábal J, Abasolo Alcázar L, Loricera J, Ruíz-Román A, Moya P, Tortosa-Cabañas M, Estrada P, Prado-Galbarro FJ, Castañeda S, Blanco R; ARTESER Project Collaborative Group. Molina-Collada J, et al. Rheumatology (Oxford). 2025 Feb 1;64(2):697-703. doi: 10.1093/rheumatology/keae042. Rheumatology (Oxford). 2025. PMID: 38244610
How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol.
Torrente-Segarra V, Fernandez Prada M, Expósito Moliner R, Garrido Puñal NP, Sánchez-Andrade Fernández A, Lamua Riazuelo JR, Olivé A, Tovar Beltrán JV; RENACER Study Group (REgistro NAcional CERtolizumab). Torrente-Segarra V, et al. Rheumatol Int. 2019 Feb;39(2):395-398. doi: 10.1007/s00296-018-4205-z. Epub 2018 Nov 24. Rheumatol Int. 2019. PMID: 30474721 No abstract available.